Consumers Injury Help
Truvada Lawsuit

Truvada Lawsuit

If you took a Gilead HIV or PrEP drug and developed kidney disease or bone damage, you may be entitled to SIGNIFICANT compensation. Gilead Sciences allegedly withheld a safer alternative to protect profits.

Get A Free Case Review
Active Litigation — Gilead Sciences

ATTENTION: TDF/PrEP DRUG USERS

If you or a loved one developed kidney or bone problems while using Truvada or similar Gilead HIV drugs, you may qualify for significant compensation!

Gilead Sciences was allegedly reluctant to develop a safer TDF alternative because it would hurt sales — knowingly exposing patients to preventable kidney and bone damage.

Find Out if You Qualify

SIGNIFICANT Compensation May Be Available

Do you already have an attorney?

Which TDF/PrEP medication have you taken?

Did you or a loved one develop any of the following problems? *

LARGE SETTLEMENT AMOUNT

COULD BE CLAIMED

How do we help YOU?

Gilead Sciences was allegedly reluctant to develop a safer TDF alternative because it would hurt sales of its existing drugs — knowingly exposing patients to preventable kidney and bone damage. The Truvada Justice Act of 2024 provides a legal pathway for affected individuals to seek compensation.

How does filing a claim work?

  • 1. Fill out our simple form. Or call to make your claim immediately.
  • 2. Get a FREE case review from our expert partners.
  • 3. We fight on your behalf for the highest compensation possible.
  • 4. Claim your settlement!
  • Remember: you only pay if you get a settlement! Our service is totally RISK FREE.

Gilead allegedly delayed a safer alternative for years — prioritizing profits over patient safety.

Gilead Sciences developed tenofovir alafenamide (TAF), a safer alternative to TDF with reduced kidney and bone toxicity, years before making it commercially available. Lawsuits allege Gilead deliberately delayed TAF to maximize revenue from TDF-based drugs including Truvada, Atripla, Complera, Stribild, and Viread.

What Is the Truvada Lawsuit?

Truvada and similar Gilead HIV drugs contain tenofovir disoproxil fumarate (TDF), which has been linked to kidney disease and bone damage. Lawsuits allege that Gilead Sciences knew about a safer formulation (TAF) but delayed its release to protect revenues from TDF-based products.

By prioritizing profits over patient safety, Gilead allegedly exposed thousands of patients to unnecessary kidney and bone complications — including chronic kidney disease, Fanconi Syndrome, osteoporosis, and bone fractures.

Who Qualifies for a Truvada Lawsuit?

Individuals who took Gilead HIV drugs including Truvada, Atripla, Complera, Stribild, or Viread and experienced kidney damage or bone damage as a result may be eligible to file a claim.

Did Gilead HIV drugs damage your kidneys or bones?

Get A Free Case Review

Health Problems Linked to Gilead TDF Drugs

Kidney Problems

  • Acute Renal Failure
  • Chronic Kidney Disease (CKD)
  • Decreased Renal Function
  • End Stage Renal Disease
  • Fanconi Syndrome

Bone Problems

  • Osteopenia
  • Osteoporosis
  • Bone Fractures (hip, spine, wrist)
  • Other Bone Complications

Gilead's Alleged Misconduct

Gilead Sciences developed tenofovir alafenamide (TAF), a safer TDF alternative with reduced kidney and bone toxicity, years before making it commercially available. Lawsuits allege Gilead deliberately delayed TAF to maximize revenue from TDF-based drugs, prioritizing profits over patient safety.

The Truvada Justice Act of 2024 strengthened the legal pathway for patients harmed by Gilead's TDF-based drugs to seek compensation.

Truvada Lawsuit Timeline and Settlements

Cases are being actively filed and evaluated. The Truvada Justice Act of 2024 strengthened the legal pathway for affected patients. Settlement amounts depend on the severity of kidney or bone damage, duration of drug use, medical costs, and other factors.

Time limits apply — contact a legal expert promptly to protect your right to compensation.